awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38851488-D28476F4-2DC3-4E41-9830-4F01EC1AFD5A
Q38851488-D28476F4-2DC3-4E41-9830-4F01EC1AFD5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38851488-D28476F4-2DC3-4E41-9830-4F01EC1AFD5A
Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective.
P2860
Q38851488-D28476F4-2DC3-4E41-9830-4F01EC1AFD5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38851488-D28476F4-2DC3-4E41-9830-4F01EC1AFD5A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a8a38a2be8c2d2cb2ef1f8e07d861230ff0b61c5
P2860
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial.